Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;24(1):40-8.
doi: 10.1016/j.jsps.2015.02.023. Epub 2015 Mar 6.

Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study

Mubashra Butt  1 , Adliah Mhd Ali  1 , Mohd Makmor Bakry  1 , Norlaila Mustafa  2
Affiliations

Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study

Mubashra Butt et al. Saudi Pharm J. 2016 Jan.

Abstract

Malaysia is situated in Western Pacific region which bears 36.17% of total diabetes mellitus population. Pharmacist led diabetes interventions have been shown to improve the clinical outcomes amongst diabetes patients in various parts of the world. Despite high prevalence of disease in this region there is a lack of reported intervention outcomes from this region. The aim of this study was to evaluate the impact of a pharmacist led intervention on HbA1c, medication adherence, quality of life and other secondary outcomes amongst type 2 diabetes patients.

Method: Type 2 diabetes mellitus patients (n = 73) attending endocrine clinic at Universiti Kebangsaan Malaysia Medical Centre (UKMMC) were randomised to either control (n = 36) or intervention group (n = 37) after screening. Patients in the intervention group received an intervention from a pharmacist during the enrolment, after three and six months of the enrolment. Outcome measures such as HbA1c, BMI, lipid profile, Morisky scores and quality of life (QoL) scores were assessed at the enrolment and after 6 months of the study in both groups. Patients in the control group did not undergo intervention or educational module other than the standard care at UKMMC.

Results: HbA1c values reduced significantly from 9.66% to 8.47% (P = 0.001) in the intervention group. However, no significant changes were noted in the control group (9.64-9.26%, P = 0.14). BMI values showed significant reduction in the intervention group (29.34-28.92 kg/m(2); P = 0.03) and lipid profiles were unchanged in both groups. Morisky adherence scores significantly increased from 5.83 to 6.77 (P = 0.02) in the intervention group; however, no significant change was observed in the control group (5.95-5.98, P = 0.85). QoL profiles produced mixed results.

Conclusion: This randomised controlled study provides evidence about favourable impact of a pharmacist led diabetes intervention programme on HbA1c, medication adherence and QoL scores amongst type 2 diabetes patients at UKMMC, Malaysia.

Keywords: Diabetes management; Diabetes mellitus; HbA1c; Intervention; Medication adherence; Pharmacist; Quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trial flow diagram in accordance with CONSORT guidelines (CONSORT, Consolidated Standards of Reporting Trials).
Figure 2
Figure 2
(a) Mean baseline and final HbA1c values in control and intervention groups and (b) mean change in HbA1c values during study duration.
See this image and copyright information in PMC

References

    1. Al Mazroui N.R., Kamal M.M. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br. J. Clin. Pharmacol. 2009;67(5):547–557. - PMC - PubMed
    1. Alhabib S., Aldraimly M. An evolving role of clinical pharmacists in managing diabetes: evidence from the literature. Saudi Pharm. J. 2014 - PMC - PubMed
    1. Al-Qazaz H.K., Hassali M.A. The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res. Clin. Practice. 2010;90(2):216–221. - PMC - PubMed
    1. Association A.D. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2002;25(Suppl 1):s74–s77.
    1. Association A.D. Dyslipidemia management in adults with diabetes. Diabetes Care. 2004;27(Suppl 1):s68–s71. - PubMed

LinkOut - more resources